The Food and Drug Administration approved Ozempic for treating patients with chronic kidney disease on Tuesday, marking the latest authorized use for Novo Nordisk’s popular drug known for ...
Ozempic injection pens have several strengths: 2 mg per 3 milliliters (mL), 2 mg/1.5 mL, 4 mg/3 mL, and 8 mg/3 mL. Each pen ...
Novo Nordisk said the Food and Drug Administration approved the diabetes-drug Ozempic to be used to help kidney-disease patients. Ozempic, or semaglutide, can now be used to reduce the risk of ...